Page 2 - Nucleus Network News Today

SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is...

Investegate announcements from Novotech, The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 - (ACN Newswire) - Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving

/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease...

(RTTNews) - Biopharmaceutical company Pulmatrix, Inc. (PULM) announced Wednesday the successful completion of a Phase 1 trial evaluating safety an...

Healthcare specialist private equity investor Genesis Capital has found another clinical trials business that it likes, New Zealand’s P3 Research.

Chinese private equity investor Hillhouse Capital is making a serious run at Australian clinical research organisation George Clinical, in what could become an interesting test of relations between Australia and China.

Affinity Equity Partners has called in law firm Corrs Chambers Westgarth to help put together a bid for clinical research company George Clinical. 

There are new opportunities for Queenslanders to make almost $10,000 while reading books, playing games and...

Clinical research is a hot game - just ask the up-for-sale George Clinical.